NCT05351580View on ClinicalTrials.gov

DiSCERN: Advanced PD Therapy Candidacy and Evaluation System

CompletedOBSERVATIONAL
Enrollment

26

Participants

Timeline

Start Date

July 21, 2022

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
Parkinson Disease
Interventions
DEVICE

DiSCERN

Smart watch Monitoring

Trial Locations (2)

44195

Cleveland Clinic, Cleveland

45219

University of Cincinnati, Cincinnati

Sponsors
All Listed Sponsors
collaborator

University of Cincinnati

OTHER

collaborator

The Cleveland Clinic

OTHER

collaborator

National Institute on Minority Health and Health Disparities (NIMHD)

NIH

collaborator

Ohio State University

OTHER

lead

Great Lakes NeuroTechnologies Inc.

INDUSTRY

NCT05351580 - DiSCERN: Advanced PD Therapy Candidacy and Evaluation System | Biotech Hunter | Biotech Hunter